UBC President’s Excellence Chair in Precision Oncology

Academic

Job Category

Faculty Bargaining

Job Title

UBC President’s Excellence Chair in Precision Oncology

Department

Faculty of Medicine | Provost and VP Academic | President's Office (Dermot Kelleher)

Posting End Date

April 19, 2024

Note: Applications will be accepted until 11:59 PM on the day prior to the Posting End Date above.

Job End Date

The expected salary for this position is $160,000 at the rank of Associate Professor and $190,000 at the rank of Professor. The Faculty of Medicine is committed to offering equitable and competitive salaries, commensurate with the qualifications and experience of the candidate. At UBC, in addition to a generous benefit package and highly valued pension plan, faculty members also have access to a comprehensive range of leaves, services, resources and career development opportunities. For more information, please visit: https://hr.ubc.ca/working-ubc.

At UBC, we believe that attracting and sustaining a diverse workforce is key to the successful pursuit of excellence in research, innovation, and learning for all faculty, staff and students. Our commitment to employment equity helps achieve inclusion and fairness, brings rich diversity to UBC as a workplace, and creates the necessary conditions for a rewarding career. ​​​​​​

The University of British Columbia (UBC) seeks to advance cancer research as a priority area with the recruitment of a President’s Excellence Chair in Precision Oncology. Precision oncology is a major multidisciplinary driver for cancer researchers at UBC, in partnership with affiliated institutions, notably BC Cancer, BC Children’s Hospital and Research Institute, BC Women’s Hospital and Research Institute, Vancouver Coastal Health, UBC Life Sciences Institute and other UBC and Faculty of Medicine Centres and Institutes.

The role of the research Chair will be to enhance UBC’s capacity in precision oncology clinical trials and facilitate the translation of new genomic assays and other biomarkers to improve our understanding of currently incurable metastatic cancers, with an interest in the use of e.g., whole genome and single cell sequencing technologies and proteomics and/or metabolomics to study treatment resistance. The Chair will work closely within a rich environment of cancer researchers at the BC Cancer Research Centre, including Canada’s largest cancer genomics facility (Canada’s Michael Smith Genome Sciences Centre), UBC, and other affiliated institutions. The Chair will be expected to lead and coordinate a program focused on precision oncology at UBC and will combine world-class research with focused and specialized clinical activities at the BC Cancer Agency’s Vancouver Centre and/or other hospital institutions as appropriate. The role is empowered by dedicated, protected time for academic activities.

The successful candidate will be a scientist or clinician scientist with established expertise in relevant areas including oncology, genomics, clinical trials, novel drug evaluation and/or development, and practical experience in working in and implementing precision oncology platforms and clinical trials. The Chair is open to an outstanding individual who is a leader in genomics and precision oncology and will provide medical leadership to support growing needs in precision oncology at UBC, enabling a structured approach to integrate cancer genomics in clinical trials and generate high-quality knowledge that will ultimately lead to improved outcomes for cancer patients. Integration across genomics, bioinformatics, clinical oncology, biomarkers, and novel drug development are required to support many disease site programs, as well as the successful growth of umbrella trials that are now being developed and led across the country by BC Cancer and other academic partners. The successful candidate will contribute to fostering an environment that promotes inclusivity and embodies values of respect, integrity, compassion, collaboration, and equity. Equity, diversity, inclusion, and justice are essential to academic excellence, as well as to fostering an inclusive community for voices that have been historically underrepresented or discouraged.

The position will include at least 70% protected academic time, with dedicated research funding to support the successful candidate for the first seven years of the program, and access to exceptional platforms in cancer biology, genomics, proteomics, conventional and molecular imaging and bioinformatics.

The successful candidate will have a MD, MD/PhD or equivalent degree with specialty training in oncology and additional training in health and/or foundational research. The candidate will have a successful track record of outstanding academic and